vs
达维塔(DVA)与Universal Health Services(UHS)财务数据对比。点击上方公司名可切换其他公司
Universal Health Services的季度营收约是达维塔的1.2倍($4.5B vs $3.6B),Universal Health Services净利率更高(8.0% vs 6.5%,领先1.5%),达维塔同比增速更快(12.3% vs 8.2%),过去两年Universal Health Services的营收复合增速更高(7.3% vs 6.6%)
达维塔是美国肾脏透析服务提供商,在美国运营2675家门诊中心,服务20.08万名患者;同时在其他11个国家布局367家门诊中心,服务4.94万名患者。公司主要服务终末期肾病患者,这类患者除非接受捐肾移植,否则通常需要终生每周接受三次透析治疗。
Universal Health Services(简称UHS)是美国财富500强企业,总部位于宾夕法尼亚州普鲁士王市,主营医院运营及各类医疗健康服务,2024年公布的总营收达158亿美元,在全球医疗服务领域具备较强的市场影响力。
DVA vs UHS — 直观对比
营收规模更大
UHS
是对方的1.2倍
$3.6B
营收增速更快
DVA
高出4.1%
8.2%
净利率更高
UHS
高出1.5%
6.5%
两年增速更快
UHS
近两年复合增速
6.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $3.6B | $4.5B |
| 净利润 | $234.2M | $358.7M |
| 毛利率 | — | — |
| 营业利润率 | 15.5% | 11.2% |
| 净利率 | 6.5% | 8.0% |
| 营收同比 | 12.3% | 8.2% |
| 净利润同比 | 43.8% | 11.5% |
| 每股收益(稀释后) | $3.22 | $5.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DVA
UHS
| Q1 26 | $3.6B | $4.5B | ||
| Q4 25 | $3.6B | $4.5B | ||
| Q3 25 | $3.4B | $4.5B | ||
| Q2 25 | $3.4B | $4.3B | ||
| Q1 25 | $3.2B | $4.1B | ||
| Q4 24 | $3.3B | $4.1B | ||
| Q3 24 | $3.3B | $4.0B | ||
| Q2 24 | $3.2B | $3.9B |
净利润
DVA
UHS
| Q1 26 | $234.2M | $358.7M | ||
| Q4 25 | $234.2M | $445.9M | ||
| Q3 25 | $150.3M | $373.0M | ||
| Q2 25 | $199.3M | $353.2M | ||
| Q1 25 | $162.9M | $316.7M | ||
| Q4 24 | $259.3M | $332.4M | ||
| Q3 24 | $214.7M | $258.7M | ||
| Q2 24 | $222.7M | $289.2M |
营业利润率
DVA
UHS
| Q1 26 | 15.5% | 11.2% | ||
| Q4 25 | 15.5% | 11.5% | ||
| Q3 25 | 14.8% | 11.6% | ||
| Q2 25 | 15.9% | 11.7% | ||
| Q1 25 | 13.6% | 11.1% | ||
| Q4 24 | 17.2% | 11.5% | ||
| Q3 24 | 16.4% | 9.7% | ||
| Q2 24 | 15.9% | 11.2% |
净利率
DVA
UHS
| Q1 26 | 6.5% | 8.0% | ||
| Q4 25 | 6.5% | 9.9% | ||
| Q3 25 | 4.4% | 8.3% | ||
| Q2 25 | 5.9% | 8.2% | ||
| Q1 25 | 5.1% | 7.7% | ||
| Q4 24 | 7.9% | 8.1% | ||
| Q3 24 | 6.6% | 6.5% | ||
| Q2 24 | 7.0% | 7.4% |
每股收益(稀释后)
DVA
UHS
| Q1 26 | $3.22 | $5.65 | ||
| Q4 25 | $3.22 | $7.01 | ||
| Q3 25 | $2.04 | $5.86 | ||
| Q2 25 | $2.58 | $5.43 | ||
| Q1 25 | $2.00 | $4.80 | ||
| Q4 24 | $3.08 | $4.94 | ||
| Q3 24 | $2.50 | $3.80 | ||
| Q2 24 | $2.50 | $4.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $700.7M | $119.0M |
| 总债务越低越好 | $10.2B | $4.7B |
| 股东权益账面价值 | $-651.1M | $7.5B |
| 总资产 | $17.5B | $15.7B |
| 负债/权益比越低杠杆越低 | — | 0.63× |
8季度趋势,按日历期对齐
现金及短期投资
DVA
UHS
| Q1 26 | $700.7M | $119.0M | ||
| Q4 25 | $700.7M | $137.8M | ||
| Q3 25 | $736.5M | $112.9M | ||
| Q2 25 | $739.4M | $137.6M | ||
| Q1 25 | $511.9M | $126.8M | ||
| Q4 24 | $846.0M | $126.0M | ||
| Q3 24 | $1.1B | $106.1M | ||
| Q2 24 | $437.2M | $128.8M |
总债务
DVA
UHS
| Q1 26 | $10.2B | $4.7B | ||
| Q4 25 | $10.2B | $4.8B | ||
| Q3 25 | $10.2B | $4.7B | ||
| Q2 25 | $10.1B | $4.6B | ||
| Q1 25 | $9.6B | $4.6B | ||
| Q4 24 | $9.2B | $4.5B | ||
| Q3 24 | $9.3B | $4.7B | ||
| Q2 24 | $8.5B | $4.5B |
股东权益
DVA
UHS
| Q1 26 | $-651.1M | $7.5B | ||
| Q4 25 | $-651.1M | $7.3B | ||
| Q3 25 | $-571.9M | $7.2B | ||
| Q2 25 | $-369.6M | $7.0B | ||
| Q1 25 | $-267.1M | $6.8B | ||
| Q4 24 | $121.1M | $6.7B | ||
| Q3 24 | $386.7M | $6.6B | ||
| Q2 24 | $632.9M | $6.5B |
总资产
DVA
UHS
| Q1 26 | $17.5B | $15.7B | ||
| Q4 25 | $17.5B | $15.5B | ||
| Q3 25 | $17.6B | $15.3B | ||
| Q2 25 | $17.5B | $15.0B | ||
| Q1 25 | $17.1B | $14.9B | ||
| Q4 24 | $17.3B | $14.5B | ||
| Q3 24 | $17.5B | $14.4B | ||
| Q2 24 | $17.0B | $14.1B |
负债/权益比
DVA
UHS
| Q1 26 | — | 0.63× | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.65× | ||
| Q1 25 | — | 0.68× | ||
| Q4 24 | 75.76× | 0.68× | ||
| Q3 24 | 23.95× | 0.71× | ||
| Q2 24 | 13.35× | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $401.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | — | 1.12× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DVA
UHS
| Q1 26 | — | $401.6M | ||
| Q4 25 | $540.7M | $574.7M | ||
| Q3 25 | $841.5M | $380.7M | ||
| Q2 25 | $324.2M | $549.0M | ||
| Q1 25 | $180.0M | $360.0M | ||
| Q4 24 | $547.6M | $658.4M | ||
| Q3 24 | $810.4M | $333.0M | ||
| Q2 24 | $798.8M | $679.3M |
自由现金流
DVA
UHS
| Q1 26 | — | — | ||
| Q4 25 | $395.3M | $293.5M | ||
| Q3 25 | $675.4M | $151.8M | ||
| Q2 25 | $203.1M | $283.0M | ||
| Q1 25 | $36.8M | $121.0M | ||
| Q4 24 | $377.0M | $412.5M | ||
| Q3 24 | $671.4M | $85.0M | ||
| Q2 24 | $674.1M | $437.9M |
自由现金流率
DVA
UHS
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 6.5% | ||
| Q3 25 | 19.7% | 3.4% | ||
| Q2 25 | 6.0% | 6.6% | ||
| Q1 25 | 1.1% | 3.0% | ||
| Q4 24 | 11.4% | 10.0% | ||
| Q3 24 | 20.6% | 2.1% | ||
| Q2 24 | 21.2% | 11.2% |
资本支出强度
DVA
UHS
| Q1 26 | — | 4.8% | ||
| Q4 25 | 4.0% | 6.3% | ||
| Q3 25 | 4.9% | 5.1% | ||
| Q2 25 | 3.6% | 6.2% | ||
| Q1 25 | 4.4% | 5.8% | ||
| Q4 24 | 5.2% | 6.0% | ||
| Q3 24 | 4.3% | 6.3% | ||
| Q2 24 | 3.9% | 6.2% |
现金转化率
DVA
UHS
| Q1 26 | — | 1.12× | ||
| Q4 25 | 2.31× | 1.29× | ||
| Q3 25 | 5.60× | 1.02× | ||
| Q2 25 | 1.63× | 1.55× | ||
| Q1 25 | 1.10× | 1.14× | ||
| Q4 24 | 2.11× | 1.98× | ||
| Q3 24 | 3.77× | 1.29× | ||
| Q2 24 | 3.59× | 2.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图